Navigating STI and AMR Trends - Implications for Public Health, Diagnostics, and Treatment

Explore the critical intersection of sexually transmitted infections and antimicrobial resistance in this comprehensive webinar that examines their profound impact on public health policy and diagnostic strategies. Delve into the rising prevalence of STIs and AMR as significant public health challenges that demand robust policies and advanced diagnostic approaches. Discover how these trends are reshaping public health initiatives and learn about the essential role of diagnostic tools in identifying key resistance mutations necessary for effective treatment decisions. Examine recent advancements in diagnostic technologies that enable accurate and timely detection of both STIs and antimicrobial resistance, ultimately improving clinical decision-making and patient outcomes. Gain valuable insights into key data that underscores the importance of refining diagnostic strategies, with particular attention to addressing the critical issue of Mycoplasma genitalium underdiagnosis and its significant clinical implications. Understand how bridging diagnostic innovation with public health policy can support a more effective and coordinated response to the evolving landscape of sexually transmitted infections and antimicrobial resistance, equipping healthcare professionals with the knowledge needed to tackle these interconnected challenges in modern healthcare settings.